• A better workers’ compensation pharmacy and ancillary benefits management experience.

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care

5 Ways We’re Innovating the Digital Experience for Claims Professionals

Claims professionals have long been the frontline of claims management – this has not changed. What has changed is just about everything else.
Read More

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims
Read More

2021 Industry Insights Survey Report

We surveyed 600+ workers’ comp professionals on the biggest industry disruptors and priorities.
Read More

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

FDA Approves Zimhi and Seglentis

A new naloxone drug and a new opioid-NSAID combination.

Nov 2021

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workforce amid COVID-19 and beyond.

Nov 2021

FDA Authorizes Booster Shots for Moderna and J&J Vaccines

All COVID-19 vaccines now have emergency use authorization for a booster dose.

Nov 2021

Cannabis in the Workplace on the Rise

One-third of employees have witnessed cannabis use during work hours.

Nov 2021

Texas Telemedicine Report

Pre-pandemic, 951 claims received telemedicine, jumping to 21,000 during the pandemic.

Nov 2021

Healthesystems at WCI & SAWCA

Visit Healthe at WCI booth #913! Plus, a recap of a SAWCA roundtable, featuring Sandy Shtab.

Nov 2021

New Drugs, Generics, and a COVID-19 Treatment Update

A new migraine medication, various generics, and more.

Oct 2021

The Long Haul: Chronic Health Complications of COVID-19

Long-term health impacts of COVID-19 can complicate claims

Oct 2021

Topical Analgesics See Increase in Utilization

A WCRI study found that in some states 17% of workers receive topical analgesics.

Oct 2021

Take the 2021 Workers’ Comp Industry Insights Survey

Take our survey and share your thoughts on where the industry is headed.

Oct 2021

Healthe Leaders to Speak at Upcoming Virtual Conferences

Take part in our virtual speaking sessions at PRIMA and Comp Laude!

Oct 2021

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.

Winter 2021/2022

Clearing the Air: Marijuana Considerations for Workers’ Comp

Public support for marijuana is at an all-time high. What does this mean for workers’ comp?

Sep 2021

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.

Winter 2021/2022

Side Effects: COVID-19-Related Healthcare and Pharmacy Trends Impacting Workers' Comp

The COVID-19 pandemic has had a profound impact on the American healthcare system, causing disruptions and driving rapid adaptations to care delivery.

Sep 2021

When Demand Exceeds Supply

Older patients and fewer physicians in workers’ comp

Sep 2021

FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way

The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.

Sep 2021

Applying AI to Leverage the Value of Unstructured Claims Data

Healthe’s Director of Enterprise Analytics discusses in WorkCompWire how natural language processing can assist with claim review, population management, and more.

Sep 2021

WCRI Publishes Report on Off-Label Gabapentinoid Use

Less than 1% of gabapentin prescriptions were prescribed for an FDA-approved diagnosis.

Sep 2021

White House Issues Vaccine Mandate

All federal employees are impacted, as are companies with 100 or more employees.

Sep 2021

Stepping Up to Take on Pandemic Ripple Effects

A message from the Chief Executive Officer

Winter 2021/2022

Ask a Clinician: What Is the Difference Between Physical and Occupational Therapies?

Healthe's clinicians tackle common workers' comp questions

Winter 2021/2022

Connect with Healthe at the 2021 National Comp Conference

Join our educational session on infectious disease safety in the workplace, and don’t miss a chance to take part in our industry survey!

Sep 2021

Classification Complications: Will Gig Workers Enter the Workers’ Comp Market?

Legislation could reclassify gig workers as employees, which could entitle them to benefits

Winter 2021/2022

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims

Winter 2021/2022

Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Adverse effects of the pandemic on women, the workforce, and workers' comp

Winter 2021/2022

New Generic Approvals

The FDA approved first-time generics for Xeljanz, two COPD medications, and more.

Aug 2021

In Claims Management, Centralized Data Means Empowered Decisions

Healthe’s Director of Product Management explains how centralized data helps claims professionals.

Aug 2021

How Opioid Policy Impacts Opioid Utilization and Disability

A new WCRI report explores the impact recent opioid legislation has had on injured worker care.

Aug 2021

The Early Impact of COVID-19 on Workers’ Comp Claims

Another WCRI report looks at non-COVID-19 claims with injuries in the first two quarters of 2019 and 2020.

Aug 2021

1 2 3 4
lockenvelopephone-handsetmenuarrow-rightcross-circle